Saturday, Apr 19, 2014 01:08 AM PDT | |
Today's Reuters Health News Headlines - Yahoo News: |
| |
Gunmen kidnap two Pakistani U.N. staff members from Karachi Saturday, Apr 19, 2014 01:08 AM PDT By Syed Raza Hassan ISLAMABAD (Reuters) - Gunmen have kidnapped two men working for the U.N. Children's Fund from Pakistan's southern city of Karachi, police said Saturday. A spokeswoman for the U.N. Children's Fund, also known as UNICEF, was not available to comment. The port city of Karachi is Pakistan's financial heart and home to 18 million people. Many neighborhoods are considered Taliban strongholds, including the area of Shorab Goth, which is near where the men were taken. Full Story | Top |
Yoga may help women ease PTSD symptoms Friday, Apr 18, 2014 02:36 PM PDT By Shereen Jegtvig NEW YORK (Reuters Health) - Women enrolled in a small study reported a reduction in symptoms of posttraumatic stress disorder (PTSD) after a series of yoga classes. However, women in a comparison group that didn't take the classes also reported a similar decline in symptoms, researchers found. "The yoga group did well - they improved in their PTSD symptoms - and our control group actually did well, which we didn't expect," Karen Mitchell told Reuters Health. Mitchell, from the National Center for PTSD at the VA Boston Healthcare System, led the new study. Full Story | Top |
Supreme Court denies Teva stay in Copaxone patent fight Friday, Apr 18, 2014 01:49 PM PDT By Lawrence Hurley WASHINGTON (Reuters) - U.S. Supreme Court Chief Justice John Roberts on Friday denied a request by Teva Pharmaceutical Industries Ltd to stay a lower-court ruling in a patent case that favored the developers of generic versions of Teva's top-selling multiple sclerosis drug. The decision could help pave the way for generic competitors of Teva's Copaxone drug to go on the market as soon as next month. Teva had sought to prevent the lower-court ruling from going into effect while the Supreme Court considers its appeal in the patent fight. At issue is a July 2013 ruling by the U.S. Court of Appeals for the Federal Circuit in favor of two teams developing cheaper generic forms of Copaxone: one comprising Novartis AG's Sandoz Inc and Momenta Pharmaceuticals Inc, and the other comprising Mylan Inc and Natco Pharma Ltd. In his decision on Friday, Roberts, in a brief opinion, wrote that he was not convinced Teva had shown the "likelihood of irreparable harm" if the application was denied, because if Teva wins the Supreme Court case it can seek damages from the generic companies for past infringement on its patents. Full Story | Top |
|
No comments:
Post a Comment